It is essential for safety
Current neuropharmacology, 12(2), 140147
It is unsuitable for individuals with salicylate hypersensitivity, bleeding disorders, or those taking anticoagulants
And restrictions on coverage arent as rigid as what we observe being proposed and implemented in Europe
Results vary by patient, and treatment should be used as part of a medically supervised plan that includes ongoing monitoring, safety guidance, and healthy lifestyle support.
The strongest associations were observed with semaglutide, which showed the most robust protective effect across all SUD categories, including an 85% reduction in AUD odds and an 87% reduction in OUD odds